Reexamination showed that all lesions disappeared after 2 cycles of sintilimab plus albumin-bound paclitaxel, nedaplatin, and palliative radiotherapy for esophageal tumors, and positron emission tomography demonstrated the absence of tumor metabolic activity following treatment. This evidence concerns the gene ALB and neoplasm.